Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 22 09:48AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-51.27 Insider Own- Shs Outstand0.15M Perf Week-1.51%
Market Cap0.37M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-4.85%
Income-7.91M PEG- EPS next Q- Inst Own13.67% Short Float- Perf Quarter-46.96%
Sales5.84M P/S0.06 EPS this Y- Inst Trans-62.34% Short Ratio1.16 Perf Half Y-44.00%
Book/sh48.28 P/B0.04 EPS next Y- ROA-65.37% Short Interest0.03M Perf Year-68.64%
Cash/sh27.53 P/C0.07 EPS next 5Y- ROE-84.44% 52W Range1.81 - 6.80 Perf YTD-18.33%
Dividend Est.- P/FCF- EPS past 5Y13.28% ROI-104.27% 52W High-71.18% Beta1.09
Dividend TTM- Quick Ratio3.07 Sales past 5Y1301.35% Gross Margin-31.87% 52W Low8.28% ATR (14)0.13
Dividend Ex-Date- Current Ratio3.17 EPS Y/Y TTM-52.93% Oper. Margin-114.77% RSI (14)41.33 Volatility5.12% 6.55%
Employees60 Debt/Eq0.05 Sales Y/Y TTM19.02% Profit Margin-135.30% Recom1.00 Target Price6.87
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q-82.61% Payout- Rel Volume0.08 Prev Close1.97
Sales Surprise-44.69% EPS Surprise- Sales Q/Q-10.20% Earnings- Avg Volume25.09K Price1.96
SMA20-1.36% SMA50-14.16% SMA200-45.99% Trades Volume186 Change-0.51%
Jan-31-24 08:00AM
Jan-05-24 08:00AM
Dec-29-23 09:00AM
Dec-14-23 08:00AM
Dec-12-23 08:00AM
08:00AM Loading…
Oct-30-23 08:00AM
Oct-18-23 08:30AM
Oct-06-23 09:00AM
Sep-27-23 03:40PM
Sep-15-23 09:00AM
Sep-12-23 08:00AM
Sep-11-23 08:30AM
Sep-01-23 10:00AM
08:45AM Loading…
Aug-30-23 08:45AM
Aug-09-23 08:00AM
Jul-28-23 08:00AM
Jul-21-23 08:00AM
May-26-23 03:00PM
May-23-23 08:00AM
Apr-28-23 08:00AM
Apr-27-23 08:00AM
Apr-19-23 08:00AM
Mar-27-23 08:00AM
Mar-13-23 08:00AM
Feb-09-23 08:00AM
Feb-07-23 10:00AM
Feb-06-23 08:00AM
Feb-03-23 08:35AM
08:00AM Loading…
Feb-01-23 02:22PM
Jan-30-23 08:00AM
Jan-24-23 08:00AM
Jan-11-23 08:00AM
Dec-06-22 08:00AM
Nov-10-22 08:00AM
Nov-09-22 08:00AM
Oct-25-22 09:14AM
Oct-13-22 08:00AM
Sep-29-22 08:00AM
Sep-02-22 08:00AM
Aug-30-22 08:00AM
Jul-28-22 08:00AM
Jul-18-22 08:00AM
Jul-14-22 08:00AM
Jul-05-22 08:00AM
Jul-01-22 08:00AM
Jun-16-22 08:00AM
May-16-22 09:00AM
Apr-08-22 08:00AM
Feb-23-22 08:00AM
Feb-22-22 08:00AM
Jan-19-22 09:00AM
Dec-21-21 08:00AM
Dec-10-21 07:30AM
Dec-09-21 07:30AM
Oct-25-21 08:30AM
Oct-04-21 08:00AM
Sep-30-21 09:00AM
Sep-28-21 08:04AM
Sep-09-21 09:00AM
Aug-31-21 09:00AM
Aug-16-21 08:00AM
Jul-26-21 08:25AM
Jul-19-21 09:27AM
Jul-09-21 08:00AM
Jun-11-21 08:00AM
Jun-01-21 08:00AM
May-13-21 09:01AM
Apr-26-21 08:00AM
Apr-12-21 09:37AM
Apr-09-21 11:15AM
Mar-04-21 07:00AM
Feb-26-21 09:20AM
Jan-25-21 04:00PM
Jan-21-21 11:30AM
Dec-02-20 09:00AM
Dec-01-20 09:50AM
Nov-23-20 04:30PM
Nov-17-20 08:30AM
Oct-01-20 08:00AM
Sep-15-20 08:00AM
Sep-11-20 08:33AM
Sep-01-20 04:45PM
Jul-20-20 08:30PM
Jul-16-20 08:02AM
Jul-15-20 08:00AM
Jun-23-20 08:00AM
Jun-18-20 08:00AM
Jun-04-20 04:49PM
May-28-20 09:00PM
May-26-20 09:22AM
May-22-20 04:05PM
May-20-20 09:15AM
Genetic Technologies Ltd. operates as a molecular diagnostics company, which engages in the provision of molecular risk assessment tests for cancer. It operates through EasyDNA, AffinityDNA and GeneType/Corporate segments. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment focuses on AffinityDNA branded test sales and expenses.The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.